Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Obstructive Lung Diseases

Free Subscription Articles published in Arch Bronconeumol Retrieve available abstracts of 78 articles: HTML format

Single Articles

October 2025
1. SANZ-FRAILE H, Herrero-Cortina B, Rovira-Ribalta N, Fernandez-Barat L, et al
   From Colour to Mechanics: A Dual Biomarker for Bronchiectasis Sputum.
   Arch Bronconeumol. 2025 Oct 4:S0300-2896(25)00340.
   PubMed    
   
   
   
2. HAMMADI A, Hoyas-Sanchez C, Romero-Linares A, Alvarez-Muro L, et al
   All-Cause and Cardiovascular Mortality With Single Inhaler Triple Therapy Versus Double Therapies for COPD: A Systematic Review and Metanalysis.
   Arch Bronconeumol. 2025;61:594-602.
   PubMed     Abstract available
   
   
   September 2025
3. ADRISH M, Hanania NA
   Inflammation Without Borders: The Interconnected Pathways of Asthma and Heart Disease.
   Arch Bronconeumol. 2025 Sep 22:S0300-2896(25)00338.
   PubMed    
   
   
   
4. ZHOU Y, Wu F, Li H, Deng Z, et al
   Effect of Carbocysteine on Exacerbations and Lung Function in Patients With Mild-to-Moderate Chronic Obstructive Pulmonary Disease: A Multicentre, Double-Blind, Randomized, Placebo-Controlled Trial.
   Arch Bronconeumol. 2025;61:528-535.
   PubMed     Abstract available
   
   
   
5. PADILLA JM, Alfaro E, Casitas R, Galera R, et al
   Characterization of Inactive COPD Patients: Barriers to Physical Activity and Perceived Impact of Inactivity.
   Arch Bronconeumol. 2025;61:555-563.
   PubMed     Abstract available
   
   
   
6. SAYAS CATALAN J, Lalmolda C, Hernandez-Voth A, Corral Blanco M, et al
   Thoracoabdominal Asynchrony in Very Severe COPD: Clinical and Functional Correlates During Exercise.
   Arch Bronconeumol. 2025;61:544-554.
   PubMed     Abstract available
   
   
   
7. ARTEAGA M, Lopez-Duque L, Laorden D, Torrado I, et al
   Inhaled Corticosteroid Reduction Effects on Asthma Outcomes After Three Years of Benralizumab Treatment in Severe Asthma Patients.
   Arch Bronconeumol. 2025 Sep 1:S0300-2896(25)00299.
   PubMed    
   
   
   August 2025
8. GIMENO-SANTOS E, Vilaro J, Arbilllaga-Etxarri A, Herrero-Cortina B, et al
   Development and Comparison of Reference Equations for the Six-Minute Walk Test in Spanish Healthy Adults Aged 45-85 Years.
   Arch Bronconeumol. 2025;61:459-466.
   PubMed     Abstract available
   
   
   July 2025
9. CHANG Q, Zhu Y, Liang H, Liu B, et al
   Association of Plasma Metabolic Profiling With Asthma Phenotypes and Exacerbation.
   Arch Bronconeumol. 2025 Jul 29:S0300-2896(25)00268.
   PubMed    
   
   
   
10. BETANCOR D, Rial MJ, Olaguibel JM, Del Pozo V, et al
    Stability of Asthma Biomarkers Over a Two-year Period Using Three Distinct Classifications in the MEGA Cohort.
    Arch Bronconeumol. 2025 Jul 5:S0300-2896(25)00230.
    PubMed    
    
    
    June 2025
11. LI XS, Gao YH
    Rethinking Pseudomonas aeruginosa in Bronchiectasis.
    Arch Bronconeumol. 2025 Jun 23:S0300-2896(25)00223.
    PubMed    
    
    
    
12. KING PT
    Childhood Pulmonary Virus Infection and Future Bronchiectasis.
    Arch Bronconeumol. 2025 Jun 7:S0300-2896(25)00213.
    PubMed    
    
    
    
13. LU L, Wan Q, Tang G, Wu F, et al
    New Classifications of COPD Severity Based on Impulse Oscillometry: A SAIO Grade Base on ECOPD Cohort in China.
    Arch Bronconeumol. 2025;61:334-340.
    PubMed     Abstract available
    
    
    May 2025
14. MAC AOGAIN M, Chotirmall SH
    Antimicrobial Resistance and Pathobionts in Bronchiectasis: An Old Problem for a New Era?
    Arch Bronconeumol. 2025 May 16:S0300-2896(25)00183.
    PubMed    
    
    
    
15. VAN DER MOLEN MC, Posthuma R, Vaes AW, Spruit MA, et al
    Metabolic Changes After Bronchoscopic Lung Volume Reduction With Endobronchial Valves in COPD Patients.
    Arch Bronconeumol. 2025;61:282-289.
    PubMed     Abstract available
    
    
    
16. CASAL-GUISANDE M, Represas-Represas C, Golpe R, Fernandez-Garcia A, et al
    Clinical and Social Characterization of Patients Hospitalized for COPD Exacerbation Using Machine Learning Tools.
    Arch Bronconeumol. 2025;61:264-273.
    PubMed     Abstract available
    
    
    
17. GOLPE R, Veiga I, Dacal-Rivas D, Blanco-Cid N, et al
    Blood Eosinophil Count During Severe Bronchiectasis Exacerbation and Risk of Hospital Readmission.
    Arch Bronconeumol. 2025 May 1:S0300-2896(25)00156.
    PubMed    
    
    
    April 2025
18. MAROTO E, Esteban Lombarte MDM, Garriga-Baraut T, Garcia Del Cerro G, et al
    Efficacy of a Digitally Supported Intervention for Children and Adolescents With Difficult-to-control Asthma (INSPIRINGKIDS): Results From a Multicentre Randomized Controlled Trial.
    Arch Bronconeumol. 2025 Apr 28:S0300-2896(25)00140.
    PubMed    
    
    
    
19. DACAL RIVAS D, Martinez-Moragon E, Plaza V, Cisneros Serrano C, et al
    Early Failure, Late Failure, and Sustained Response to Biologics in Severe Asthma: A Long-term, Real-world, Multicentre study.
    Arch Bronconeumol. 2025 Apr 26:S0300-2896(25)00139.
    PubMed     Abstract available
    
    
    
20. GARCIA-OLIVE I, Radua J, Hernandez Biette A, Bruguera N, et al
    Evaluating the Utility of Biologic Therapies in Patients With Severe Asthma and Comorbid Bronchiectasis: A Systematic Review With Meta-analysis of Retrospective Studies.
    Arch Bronconeumol. 2025 Apr 26:S0300-2896(25)00149.
    PubMed    
    
    
    
21. MUNOZ-SANCHEZ B, Leon-Lloreda A, Romero-Falcon A, Medina-Gallardo JF, et al
    Identification of Fractional Exhaled Nitric Oxide Cutoff Values for the Diagnosis of Asthma.
    Arch Bronconeumol. 2025 Apr 2:S0300-2896(25)00121.
    PubMed    
    
    
    
22. OSCULLO G, Mendez R, Olveira C, Giron R, et al
    Effect of N-Acetylcysteine on Bronchiectasis in a Real-life Study. Data From the Spanish RIBRON Registry.
    Arch Bronconeumol. 2025;61:196-202.
    PubMed     Abstract available
    
    
    March 2025
23. RODRIGUEZ-CHIARADIA DA, Torres-Castro R, Piccari L, Garcia-Ortega A, et al
    A Systematic Review and Expert Recommendation on the Diagnosis of Pulmonary Hypertension Associated With Lung Disease: A Position Paper of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR).
    Arch Bronconeumol. 2025 Mar 28:S0300-2896(25)00112.
    PubMed     Abstract available
    
    
    
24. MARTIN-GONZALEZ E, Perez-Garcia J, Martin-Almeida M, Hernandez-Perez JM, et al
    Genome-wide Association Study of Asthma Exacerbations in the Spanish Population.
    Arch Bronconeumol. 2025 Mar 20:S0300-2896(25)00091.
    PubMed    
    
    
    
25. FERNANDEZ-BARAT L, Lopez-Aladid R, Alcaraz-Serrano V, Vazquez N, et al
    Clinical and Lung Microbiome Impact of Chronic Versus Intermittent Pseudomonas aeruginosa Infection in Bronchiectasis.
    Arch Bronconeumol. 2025 Mar 18:S0300-2896(25)00082.
    PubMed     Abstract available
    
    
    
26. JIN KN, Lee HJ, Park H, Lee JK, et al
    Mucus Plugs as Precursors to Exacerbation and Lung Function Decline in COPD Patients.
    Arch Bronconeumol. 2025;61:138-146.
    PubMed     Abstract available
    
    
    
27. BETANCOR D, Olaguibel JM, Del Pozo V, Alvarez Puebla MJ, et al
    FEV(1)Q as a Predictive Metric for Asthma Outcomes.
    Arch Bronconeumol. 2025 Mar 1:S0300-2896(25)00072.
    PubMed    
    
    
    February 2025
28. OSCULLO G, Bekki A, Olveira C, Giron R, et al
    Persistent Blood Eosinophilia and Eosinopenia: Relationship with Outcomes in Bronchiectasis.
    Arch Bronconeumol. 2025 Feb 4:S0300-2896(25)00043.
    PubMed     Abstract available
    
    
    
29. BERNABEU-MORA R, Valera-Novella E, Bernabeu-Serrano ET, Soler-Cataluna JJ, et al
    Five-Repetition Sit-to-Stand Test as Predictor of Mortality in High Risk COPD Patients.
    Arch Bronconeumol. 2025;61:90-95.
    PubMed     Abstract available
    
    
    January 2025
30. OSCULLO G, Bekki A, Martinez-Garcia MA
    Microbiome, Metabolome and Complexity in Bronchiectasis: The Future is Here.
    Arch Bronconeumol. 2025 Jan 31:S0300-2896(25)00033.
    PubMed    
    
    
    
31. ZHANG XX, He ZF, He JH, Chen ZM, et al
    Sputum Microbiota Correlates With Metabolome and Clinical Outcomes in Asthma-Bronchiectasis Overlap.
    Arch Bronconeumol. 2025 Jan 6:S0300-2896(25)00006.
    PubMed     Abstract available
    
    
    
32. ROMERO FALCON MAA, Leon Lloreda A, Gomez-Bastero A
    Experience With the Use of Biological Therapy for Asthma Control During Pregnancy: Preliminary Results.
    Arch Bronconeumol. 2025 Jan 6:S0300-2896(25)00004.
    PubMed    
    
    
    
33. ERSOZ H, Torres-Duran M, Turner AM, Tanash H, et al
    Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry.
    Arch Bronconeumol. 2025;61:22-30.
    PubMed     Abstract available
    
    
    December 2024
34. CHEN X, Li D, Ma Z
    A Commentary on 'Effect of the Antibody-Mediated Immune Responses on COPD, Asthma, and Lung Function: A Mendelian Randomization Study'.
    Arch Bronconeumol. 2024 Dec 5:S0300-2896(24)00454.
    PubMed    
    
    
    
35. ALVARADO-MIRANDA M, Solano A, Marsico S, Nunez-Robainas A, et al
    Clinical Implications of Functional Imaging in the Assessment of Bronchiectasis-Associated Sarcopenia.
    Arch Bronconeumol. 2024 Dec 4:S0300-2896(24)00453.
    PubMed     Abstract available
    
    
    November 2024
36. ANSEDE-BORDONABA G, Giron-Moreno RM, Martinez-Vergara A
    Ulcerative Colitis, Bronchiectasis and Tofacitinib.
    Arch Bronconeumol. 2024 Nov 22:S0300-2896(24)00438.
    PubMed    
    
    
    
37. DE LUCA GR, Diciotti S, Mascalchi M
    The Pivotal Role of Baseline LDCT for Lung Cancer Screening in the Era of Artificial Intelligence.
    Arch Bronconeumol. 2024 Nov 22:S0300-2896(24)00439.
    PubMed     Abstract available
    
    
    October 2024
38. GUIXING X, Yilin L, Huaying F, Fanrong L, et al
    Effect of the Antibody-mediated Immune Responses on COPD, Asthma, and Lung Function: A Mendelian Randomization Study.
    Arch Bronconeumol. 2024 Oct 22:S0300-2896(24)00406.
    PubMed     Abstract available
    
    
    
39. PADILLA-GALO A, Rubio-Moreno M, Valencia-Azcona B
    Asthma-COPD Overlap - A Gateway to Biological Treatment.
    Arch Bronconeumol. 2024 Oct 22:S0300-2896(24)00409.
    PubMed    
    
    
    
40. ALVAREZ-GUTIERREZ FJ, Casas-Maldonado F, Soto-Campos G
    Reply to Letter: The Importance of Multidisciplinary Teams in the Evaluation of the Remission of Chronic Rhinosinusitis in Severe Asthma.
    Arch Bronconeumol. 2024 Oct 9:S0300-2896(24)00377.
    PubMed    
    
    
    
41. SCHILFARTH P, Maurac A, Macey J, Decloedt C, et al
    Sleep Quality in Patients Receiving Long-term NIV: A Prospective Cohort Study.
    Arch Bronconeumol. 2024;60:652-655.
    PubMed    
    
    
    
42. PINERO-GUTIERREZ P, Villar-Alvarez F, Asensio-Mathews P, Gonzalez-Peinado D, et al
    Organizing Pneumonia Secondary to ASIA Syndrome.
    Arch Bronconeumol. 2024;60:658-659.
    PubMed    
    
    
    
43. JO YS, Rhee CK, Kim SH, Lee H, et al
    Spirometric Transition of at Risk Individuals and Risks for Progression to Chronic Obstructive Pulmonary Disease in General Population.
    Arch Bronconeumol. 2024;60:634-642.
    PubMed     Abstract available
    
    
    
44. KERGET B, Cinar I, Akdag BN, Yesilyurt M, et al
    New Indicators of Exercise Capacity and Respiratory Function in COPD Patients: The Role of Gastrocnemius Muscle Oxygenation and Elastography Levels.
    Arch Bronconeumol. 2024;60:643-645.
    PubMed    
    
    
    
45. KHO SS, Ing SK, Tie ST
    The Effect of Bronchoscopic Lung Volume Reduction on Hemidiaphragm Excursion.
    Arch Bronconeumol. 2024;60:668-669.
    PubMed    
    
    
    September 2024
46. PLAZA V, Garcia G, Perez de Llano L, Quirce S, et al
    Initiating Biological Treatment of Asthma: When is the Right Time?
    Arch Bronconeumol. 2024 Sep 24:S0300-2896(24)00364.
    PubMed    
    
    
    
47. TIOTIU CEPUC A, Steiropoulos P, Novakova S, Nedeva D, et al
    Airway Remodeling in Asthma: Mechanisms, Diagnosis, Treatment, and Future Directions.
    Arch Bronconeumol. 2024 Sep 24:S0300-2896(24)00367.
    PubMed     Abstract available
    
    
    
48. TRAVERSI L, Garriga-Grimau L, Moreno-Galdo A, Polverino E, et al
    The In-between: Time to Talk About Bronchiectasis in Adolescents and Their Transition to Adult Care.
    Arch Bronconeumol. 2024 Sep 24:S0300-2896(24)00359.
    PubMed     Abstract available
    
    
    
49. BARREIRO E, Gea J
    Muscle Fatigability of Patients With Severe COPD and Chronic Respiratory Failure: The Contribution of Respiratory Factors.
    Arch Bronconeumol. 2024;60:543-544.
    PubMed    
    
    
    
50. MALLAH N, Urbieta AD, Rivero-Calle I, Gonzalez-Barcala FJ, et al
    New Vaccines for Chronic Respiratory Patients.
    Arch Bronconeumol. 2024;60:565-575.
    PubMed     Abstract available
    
    
    
51. VILLENEUVE T, Guilleminault L, Guibert N
    Sequential and Multimodal Bronchoscopic Interventions for COPD: Toward a Highly Personalized Interventional Pulmonology?
    Arch Bronconeumol. 2024;60:600-601.
    PubMed    
    
    
    August 2024
52. ALOBID I, Bernal-Sprekelsen M, Mullol J
    The Importance of Multidisciplinary Teams in the Evaluation of the Remission of Chronic Rhinosinusitis in Severe Asthma.
    Arch Bronconeumol. 2024 Aug 31:S0300-2896(24)00317.
    PubMed    
    
    
    
53. JACOME C, Jacome M, Correia S, Flores I, et al
    Effectiveness, Adherence and Safety of Home High Flow Nasal Cannula in Chronic Respiratory Disease and Respiratory Insufficiency: A Systematic Review.
    Arch Bronconeumol. 2024;60:490-502.
    PubMed     Abstract available
    
    
    July 2024
54. GIL-MARTINEZ M, Rodrigo-Munoz JM, Antonio Canas J, Sastre J, et al
    Sputum Proteome Reveals Differences Between Eosinophilic and Non-eosinophilic Asthma Phenotypes.
    Arch Bronconeumol. 2024 Jul 20:S0300-2896(24)00273.
    PubMed    
    
    
    
55. WU X, Deng Z, Wu F, Zheng Y, et al
    Clinical Characteristics and 2-Year Outcomes of Chronic Obstructive Pulmonary Disease Patients With High Blood Eosinophil Counts: A Population-based Prospective Cohort Study in China.
    Arch Bronconeumol. 2024;60:402-409.
    PubMed     Abstract available
    
    
    
56. AGUSTI A, Lopez-Campos JL, Miravitlles M, Soler-Cataluna JJ, et al
    Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial.
    Arch Bronconeumol. 2024;60:417-422.
    PubMed     Abstract available
    
    
    
57. PANERONI M, Cavicchia A, Beatrice S, Bertacchini L, et al
    The Influence of Lung Function and Respiratory Muscle Strength on Quadriceps Muscle Fatigability in COPD Patients Under Long-term Oxygen Therapy.
    Arch Bronconeumol. 2024;60:410-416.
    PubMed     Abstract available
    
    
    June 2024
58. COSIO BG, Shafiek H, Torrego A
    Bronchoscopy in Severe Asthmatics: Is it a Safe Procedure?
    Arch Bronconeumol. 2024 Jun 18:S0300-2896(24)00224.
    PubMed    
    
    
    
59. MA D, Munoz X, Ojanguren I, Romero-Mesones C, et al
    Increased TGFbeta1, VEGF and IFN-gamma in the Sputum of Severe Asthma Patients With Bronchiectasis.
    Arch Bronconeumol. 2024 Jun 7:S0300-2896(24)00221.
    PubMed     Abstract available
    
    
    
60. DE MIGUEL-DIEZ J, Gomez Doblas JJ
    Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: Response to Additional Considerations.
    Arch Bronconeumol. 2024;60:392-393.
    PubMed    
    
    
    
61. GOLPE R, Figueira-Goncalves JM
    Comment on "Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease".
    Arch Bronconeumol. 2024;60:391.
    PubMed    
    
    
    
62. FERNANDEZ-VILLAR A, Cimas Hernando JE, Figueira Goncalves JM, De Miguel Diez J, et al
    Continuity of Care in Chronic Obstructive Pulmonary Disease Exacerbations: Challenges and Priorities.
    Arch Bronconeumol. 2024;60:327-329.
    PubMed    
    
    
    May 2024
63. GONZALEZ J, Seijo LM, de-Torres JP, Benitez ID, et al
    Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP.
    Arch Bronconeumol. 2024 May 16:S0300-2896(24)00170.
    PubMed     Abstract available
    
    
    
64. GARRIGA-GRIMAU L, Sanz-Santiago V, Moreno-Galdo A
    Implementation of the Spanish Paediatric Bronchiectasis Registry (Child-BEAR-es Registry).
    Arch Bronconeumol. 2024 May 6:S0300-2896(24)00143.
    PubMed    
    
    
    
65. FORCADA BARREDA C, Fuentes Gago MG, Gomez Hernandez MT
    Subconjunctival Emphysema After Videothoracoscopic Segmentectomy.
    Arch Bronconeumol. 2024 May 4:S0300-2896(24)00138.
    PubMed    
    
    
    
66. BALLESTEROS-REVIRIEGO G, Arbillaga-Etxarri A, Marti JD
    Inspiratory Muscle Training: Back to Basics Must be the First Step?
    Arch Bronconeumol. 2024;60:267-268.
    PubMed    
    
    
    
67. PAPI A, Alfano F, Bigoni T, Mancini L, et al
    N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses.
    Arch Bronconeumol. 2024;60:269-278.
    PubMed     Abstract available
    
    
    
68. CUENCA PERIS S, Martinez Tomas R, Briones Gomez A, Cases Viedma E, et al
    What to Do When Endobronchial Volume Reduction Treatment Fails.
    Arch Bronconeumol. 2024;60:319-320.
    PubMed    
    
    
    April 2024
69. CAKIR E, Ibis E, Yuzuak E
    Probable Invasive Aspergillosis Causing Massive Subcutaneous Emphysema by Rupturing the Pleura and Forming a Bronchopleural Fistula.
    Arch Bronconeumol. 2024 Apr 30:S0300-2896(24)00131.
    PubMed    
    
    
    
70. MASELLI DJ, Diaz AA
    Mortality Risk in Bronchiectasis.
    Arch Bronconeumol. 2024 Apr 24:S0300-2896(24)00114.
    PubMed    
    
    
    
71. ALVAREZ-GUTIERREZ FJ, Casas-Maldonado F, Soto-Campos G, Blanco-Aparicio M, et al
    Spanish Consensus on Remission in Asthma (REMAS).
    Arch Bronconeumol. 2024 Apr 23:S0300-2896(24)00109.
    PubMed     Abstract available
    
    
    
72. PAN CX, He ZF, Lin SZ, Yue JQ, et al
    Clinical Characteristics and Outcomes of the Phenotypes of COPD-Bronchiectasis Association.
    Arch Bronconeumol. 2024 Apr 23:S0300-2896(24)00110.
    PubMed     Abstract available
    
    
    
73. MAKRINIOTI H, Zhu Z, Saglani S, Camargo CA, et al
    Infant Bronchiolitis Endotypes and the Risk of Developing Childhood Asthma: Lessons From Cohort Studies.
    Arch Bronconeumol. 2024;60:215-225.
    PubMed     Abstract available
    
    
    
74. DE MIGUEL-DIEZ J, Nunez Villota J, Santos Perez S, Manito Lorite N, et al
    Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease.
    Arch Bronconeumol. 2024;60:226-237.
    PubMed     Abstract available
    
    
    March 2024
75. GAO YH, Zhu YN, Bai JW, Liang S, et al
    Severe Pulmonary Hypertension Increased All-cause Mortality in Patients With Bronchiectasis.
    Arch Bronconeumol. 2024 Mar 23:S0300-2896(24)00073.
    PubMed    
    
    
    
76. CHANG AB, Dharmage SC, Marchant JM, McCallum GB, et al
    Improving the Diagnosis and Treatment of Paediatric Bronchiectasis Through Research and Translation.
    Arch Bronconeumol. 2024 Mar 10:S0300-2896(24)00062.
    PubMed     Abstract available
    
    
    
77. URRUTIA-ROYO B, Garcia-Olive I, Compte M, Folgado C, et al
    Effect of Comorbidities and Gender Differences in Survival in Patients With Bronchiectasis.
    Arch Bronconeumol. 2024 Mar 2:S0300-2896(24)00055.
    PubMed    
    
    
    
78. VITACCA M, Malovini A, Paneroni M, Spanevello A, et al
    Predicting Response to In-Hospital Pulmonary Rehabilitation in Individuals Recovering From Exacerbations of Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2024;60:153-160.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.